Mohindra, Nisha
Northwestern University
6 papers on CoChatORCID 0000-0001-5913-1716
Most cited papers
- Verified
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
Thompson, J. A., Schneider, B. J., Brahmer, J., Andrews, S., Armand, P., Bhatia, S., Budde, L. E., Costa, L., Davies, M., Dunnington, D., et al. (2019) · Journal of the National Comprehensive Cancer Network
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 570
- Verified
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement
Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., et al. (2021) · American Journal of Transplantation
Transplantation: Methods and OutcomesOrgan and Tissue Transplantation Research
Cited by 163
- Verified
A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes
Chae, Y. K., Chiec, L., Mohindra, N., Gentzler, R., Patel, J., & Giles, F. (2017) · Cancer Immunology, Immunotherapy
Cancer Immunotherapy and BiomarkersDiabetes and associated disorders
Cited by 121
- Verified
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
Chae, Y. K., Davis, A. A., Carneiro, B. A., Chandra, S., Mohindra, N., Kalyan, A., Kaplan, J., Matsangou, M., Pai, S., Costa, R., et al. (2016) · Oncotarget
Cancer Genomics and DiagnosticsLung Cancer Treatments and Mutations
Cited by 110
- Verified
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., et al. (2021) · American Journal of Transplantation
Cutaneous Melanoma Detection and ManagementTransplantation: Methods and Outcomes
Cited by 87
- Verified
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
Schulte, B., Mohindra, N., Milhem, M., Attia, S., Robinson, S., Monga, V., Hirbe, A. C., Oppelt, P., Charlson, J., Helenowski, I., et al. (2021) · British Journal of Cancer
Sarcoma Diagnosis and TreatmentCancer therapeutics and mechanisms
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free